Updated:
Chiesi Ventures
Chiesi Ventures is a venture capital firm founded in 2014 in Boston, Massachusetts. It focuses on early-stage development opportunities in small molecules,...
Chiesi Ventures
Chiesi Ventures is a venture capital firm founded in 2014 in Boston, Massachusetts. It focuses on early-stage development opportunities in small molecules, biologics, advanced therapies, and reformulation technologies and devices. Chiesi Ventures has made 15 investments, including a Series C investment in Glycomine on April 16, 2025, and has facilitated 3 portfolio exits, including Aura Biosciences on October 29, 2021.
General information
Firm type
Venture Capital
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, United States
Sector focus
Frequently asked questions
What stages does Chiesi Ventures target?
Available records list early-stage, seed, and start-up investments as the stated focus.
Where is Chiesi Ventures headquartered?
The firm is based in Boston, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: